<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40">
 <label>40</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ruella</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Barrett</surname>
    <given-names>DM</given-names>
   </name>
   <name>
    <surname>Kenderian</surname>
    <given-names>SS</given-names>
   </name>
   <name>
    <surname>Shestova</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Hofmann</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Perazzelli</surname>
    <given-names>J</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies</article-title>. 
  <source>J Clin Invest</source> (
  <year>2016</year>) 
  <volume>126</volume>(
  <issue>10</issue>):
  <page-range>3814–26</page-range>.  
  <pub-id pub-id-type="doi">10.1172/JCI87366</pub-id>
 </mixed-citation>
</ref>
